BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24844148)

  • 1. ATP-binding cassette transporter A1: from metabolism to neurodegeneration.
    Koldamova R; Fitz NF; Lefterov I
    Neurobiol Dis; 2014 Dec; 72 Pt A():13-21. PubMed ID: 24844148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration.
    Koldamova R; Fitz NF; Lefterov I
    Biochim Biophys Acta; 2010 Aug; 1801(8):824-30. PubMed ID: 20188211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.
    Zhao J; Fu Y; Liu CC; Shinohara M; Nielsen HM; Dong Q; Kanekiyo T; Bu G
    J Biol Chem; 2014 Apr; 289(16):11282-11292. PubMed ID: 24599963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice.
    Carter AY; Letronne F; Fitz NF; Mounier A; Wolfe CM; Nam KN; Reeves VL; Kamboh H; Lefterov I; Koldamova R
    PLoS One; 2017; 12(2):e0172161. PubMed ID: 28241068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.
    Corona AW; Kodoma N; Casali BT; Landreth GE
    J Neuroimmune Pharmacol; 2016 Mar; 11(1):61-72. PubMed ID: 26175148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.
    Koldamova R; Staufenbiel M; Lefterov I
    J Biol Chem; 2005 Dec; 280(52):43224-35. PubMed ID: 16207713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.
    Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ
    J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain.
    Kim J; Yoon H; Horie T; Burchett JM; Restivo JL; Rotllan N; Ramírez CM; Verghese PB; Ihara M; Hoe HS; Esau C; Fernández-Hernando C; Holtzman DM; Cirrito JR; Ono K; Kim J
    J Neurosci; 2015 Nov; 35(44):14717-26. PubMed ID: 26538644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene.
    Boehm-Cagan A; Michaelson DM
    J Neurosci; 2014 May; 34(21):7293-301. PubMed ID: 24849361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease.
    Wahrle SE; Jiang H; Parsadanian M; Kim J; Li A; Knoten A; Jain S; Hirsch-Reinshagen V; Wellington CL; Bales KR; Paul SM; Holtzman DM
    J Clin Invest; 2008 Feb; 118(2):671-82. PubMed ID: 18202749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liver X receptor agonist TO901317 on cognitive function in APP/PS1 double transgenic mice with Alzheimer
    Luo Y; Tan X; Zhang X; Li Y; Huang J; Deng Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1324-1331. PubMed ID: 36411683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3.
    Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L
    Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.
    Donkin JJ; Stukas S; Hirsch-Reinshagen V; Namjoshi D; Wilkinson A; May S; Chan J; Fan J; Collins J; Wellington CL
    J Biol Chem; 2010 Oct; 285(44):34144-54. PubMed ID: 20739291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway.
    Pamir N; Hutchins P; Ronsein G; Vaisar T; Reardon CA; Getz GS; Lusis AJ; Heinecke JW
    J Lipid Res; 2016 Feb; 57(2):246-57. PubMed ID: 26673204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
    Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCA1 and nascent HDL biogenesis.
    Wang S; Smith JD
    Biofactors; 2014; 40(6):547-54. PubMed ID: 25359426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease.
    Wahrle SE; Jiang H; Parsadanian M; Hartman RE; Bales KR; Paul SM; Holtzman DM
    J Biol Chem; 2005 Dec; 280(52):43236-42. PubMed ID: 16207708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.